The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval
Journal Article
Overview
publication date
- December 1, 2020
has subject area
- Adnexal Diseases - Ovarian Neoplasms
- Combined Modality Therapy
- Combined Modality Therapy - Chemotherapy, Adjuvant
- Cytoreduction Surgical Procedures
- Drug Therapy - Antineoplastic Combined Chemotherapy Protocols
- Drug Therapy - Chemotherapy, Adjuvant
- Drug Therapy, Combination - Antineoplastic Combined Chemotherapy Protocols
- Endocrine System Diseases - Ovarian Neoplasms
- Environment and Public Health - Follow-Up Studies
- Environment and Public Health - Survival Rate
- Epidemiologic Measurements - Survival Rate
- Female
- Female Urogenital Diseases - Ovarian Neoplasms
- Gonadal Disorders - Ovarian Neoplasms
- Health Care Evaluation Mechanisms - Follow-Up Studies
- Humans
- Inflammation
- Investigative Techniques - Follow-Up Studies
- Investigative Techniques - Survival Rate
- Neoadjuvant Therapy
- Neoplasms by Site - Ovarian Neoplasms
- Population Characteristics - Survival Rate
- Prognosis
- Therapeutics - Antineoplastic Combined Chemotherapy Protocols
- Tumor Microenvironment
has restriction
- green
Date in CU Experts
- September 23, 2020 1:57 AM
Full Author List
- Jordan KR; Sikora MJ; Slansky JE; Minic A; Richer JK; Moroney MR; Hu J; Wolsky RJ; Watson ZL; Yamamoto TM
author count
- 15
citation count
- 23
published in
- Clinical Cancer Research Journal
Other Profiles
International Standard Serial Number (ISSN)
- 1078-0432
Electronic International Standard Serial Number (EISSN)
- 1557-3265
Digital Object Identifier (DOI)
Additional Document Info
start page
- 6362
end page
- 6373
volume
- 26
issue
- 23